AU

Abdulwahid Usman Maknojia

Active Director Director DIN 02133554
DIN 02133554 First appointment Feb 2017 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Abdulwahid Usman Maknojia

Data last updated:

Abdulwahid Usman Maknojia is a Director at Muqawwi Unani Medicine Remedies Private Limited (since 2017). The company operates in Healthcare.

DIN 02133554
Primary Designation Director
Industry Healthcare
First Appointment 13 Feb 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Feb 20172017Active

Board colleagues of Abdulwahid Usman Maknojia

Directorship timeline

Open interactive timeline →
Muqawwi Unani Medicine Remedies Private Limited
Premium access

Shareholding and investment profile for Abdulwahid Usman Maknojia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdulwahid Usman Maknojia

Abdulwahid Usman Maknojia currently holds 1 directorship: Muqawwi Unani Medicine Remedies Private Limited (Director, since 13 Feb 2017).

Abdulwahid Usman Maknojia was first appointed on 13 Feb 2017 as Director at Muqawwi Unani Medicine Remedies Private Limited.

The current boards of Abdulwahid Usman Maknojia's companies include Huzaifa Abdul Wahid Maknojia (Muqawwi Unani Medicine Remedies Private Limited), Usama Maknojia Abdul Wahid (Muqawwi Unani Medicine Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available